Declopramide (3-Chloroprocainamide) is an orally active antineoplastic agent that inhibits the proliferation of HL60 and K562 cancer cells and suppresses the growth of human astrocytoma (T24) in mouse models; it induces apoptosis in 70Z/3 cells by inhibiting IκBα degradation and subsequent NF-κB activation; it also serves as a chemosensitizing agent in research.